ProKidney Corp. held its 2025 Annual General Meeting of Shareholders on May 29, 2025. During the meeting, shareholders approved several proposals. The Domestication Proposal, which involves changing the company's jurisdiction of incorporation, was approved. Advisory Charter Proposal E, concerning provisions for altering bylaws and certain corporate opportunities, received approval. Advisory Charter Proposal B, regarding the authorization of shares and removal of directors for cause, was also approved. Additionally, nominees for the Board of Directors were elected.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.